Professor Dame Kay Davies is the Dr Lee's Professor of Anatomy and Associate Head, Development, Impact and Equality, Medical Sciences Division, University of Oxford. Her research interests cover the molecular analysis of neuromuscular and neurological disease, particular Duchenne muscular dystrophy (DMD). She has an active interest in the ethical implications of genetics research and the public understanding of science. She has considerable experience of biotechnology companies as a conduit for translating the results of experimental science into new therapeutics and diagnostics. She co-founder of Summit Therapeutics and Oxstem. She is a founding editor of “Human Molecular Genetics” and a founding fellow of the UK Academy of Medical Sciences. She is a Fellow of the Royal Society and a Member of the European Molecular Biology Organization (EMBO). She has been a Governor of the Wellcome Trust since 2008 and became Deputy Chairman in October 2013. She was made Dame Commander of the British Empire for services to science in 2008. Professor Davies will discuss how her interest in the muscle wasting disease, Duchenne muscular dystrophy, moved from the gene to the clinic via basic research and the foundation of a start-up company.
- Rhodes House